What Is Nodular Asymmetry in the Breast?

Nodular asymmetry is a descriptive term used in breast imaging to describe a small, rounded area of tissue that looks denser on one side of the breast than the corresponding area on the other side. It is not a diagnosis but a radiological observation, most often spotted on a routine mammogram. The vast majority of the time it turns out to be normal breast tissue that simply grew in a slightly uneven pattern, though occasionally it warrants further imaging or a biopsy to rule out something more concerning.

How Radiologists Categorize Breast Asymmetries

When a radiologist reads your mammogram, they compare each breast to the other, looking for areas where tissue density does not match. The American College of Radiology’s Breast Imaging Reporting and Data System (BI-RADS) recognizes several types of asymmetric findings, including asymmetric breast tissue, densities visible on only one mammographic view, architectural distortion, and focal asymmetric densities.¹ “Nodular asymmetry” is not one of the official BI-RADS terms, but it is widely used in clinical practice to describe a focal asymmetry that has a somewhat rounded, nodule-like shape. Think of it as a radiologist’s shorthand for saying, “There’s a small clump of denser tissue here that doesn’t have an obvious match on the other breast.”

The distinction between types of asymmetry matters because each carries a slightly different set of odds. A global asymmetry affecting a large region of one breast is almost always normal variation. A focal asymmetry that is new or growing (called a “developing asymmetry”) gets more attention, because change over time raises the possibility that something is actively happening in that tissue.² A nodular asymmetry sits somewhere in the middle of this spectrum: it is localized enough to catch the radiologist’s eye, but often lacks the spiculated edges or distortion that would immediately suggest cancer.

Why Breasts Are Almost Never Perfectly Symmetric

Before worrying about what “asymmetry” on a mammogram report means, it helps to know that virtually no one has perfectly matching breasts. A study using 4D photography found that every single participant had some measurable degree of breast or chest wall asymmetry, with differences in one or more dimensions appearing in about 82% of patients even when the analysis focused only on soft tissue.³ The underlying chest wall itself is uneven in most people, with research suggesting the left side tends to be slightly wider.⁴

This natural unevenness is exactly why a mammogram might show an area of tissue density on one breast without a mirror image on the other. Most of the time, the radiologist recognizes it as a normal anatomical variant and moves on. When the asymmetry has a more nodular or focal appearance, or when it wasn’t there on your last mammogram, additional investigation is considered worthwhile.

Common Benign Causes

When a nodular asymmetry does get worked up with additional imaging or a biopsy, the result is benign far more often than not. Several conditions routinely produce this kind of finding.

Focal fibrosis: A localized area of dense, fibrous connective tissue. It is one of the most commonly diagnosed benign breast lesions found on imaging-guided core biopsy, and it can show up as a mass, a density, or a cluster of calcifications on a mammogram.⁵ At the tissue level, focal fibrosis can take on several patterns, including a nodular form, and about a third of cases in one study presented as asymmetric densities on mammography.⁶
Pseudoangiomatous stromal hyperplasia (PASH): A benign overgrowth of the breast’s supportive tissue. When it forms a discrete lump (nodular PASH), it can look suspicious on imaging. One case report described a woman with nine separate PASH masses across both breasts, all confirmed benign.⁷ In a more dramatic presentation, multifocal PASH has been documented causing significant asymmetric breast enlargement while remaining entirely benign.⁸
Radial scars and complex sclerosing lesions: These benign lesions can mimic breast cancer on imaging, typically appearing as a focal area of architectural distortion, a spiculated mass, or an asymmetric density, often without any central tumor.⁹ The name “radial scar” sounds alarming, but it is a tissue pattern, not a scar from trauma.
Normal glandular tissue: Sometimes the nodular-looking area is simply a small island of normal breast gland tissue that happens to be denser than what surrounds it. This is especially common in women with heterogeneously dense breasts, where tissue density varies considerably across the breast.

Other benign possibilities include cysts, fat necrosis from an old injury, and lymph nodes located within the breast tissue. The key takeaway is that “asymmetry” on a mammogram report is not synonymous with “something is wrong.” It is more like a flag that says, “Let’s take a closer look.”

When a Nodular Asymmetry Raises Concern

Although uncommon, a nodular or focal asymmetry can occasionally represent a malignancy. In a study covering more than 18,000 core-needle biopsies over seven and a half years, only 42 cases of cancer presenting as an asymmetry were diagnosed, representing about 0.2% of all biopsies performed.¹⁰ Among those 42 malignancies, the majority (about 71%) were invasive carcinomas, roughly 21% were ductal carcinoma in situ (DCIS), and a small fraction were lymphomas.

Certain types of breast cancer are more likely to show up as an asymmetry rather than an obvious mass. Invasive lobular carcinoma, which grows in sheets rather than forming a discrete lump, has a particular tendency to appear as an asymmetric density, especially in women aged 70 and older.¹¹ DCIS, which is cancer confined to the milk ducts, should also be considered in the differential diagnosis when an asymmetry or focal asymmetry is seen on mammography, even if the typical microcalcifications are absent.¹²

Radiologists weigh several factors when deciding how suspicious a nodular asymmetry looks. A palpable lump that lines up with the asymmetric density raises the level of concern significantly.¹³ So does a density that is new compared to a prior mammogram, one that appears to be growing, or one with irregular or spiculated margins. Stable, smooth-bordered asymmetries that have not changed over several years of screening are much less worrisome.

How Radiologists Investigate Further

If a nodular asymmetry needs further evaluation, the first step is usually additional mammographic views. Spot compression views, which use a smaller paddle to press on just the area of interest, can help determine whether the density is real or simply an artifact of overlapping tissue.

Digital breast tomosynthesis (commonly called 3D mammography) has become increasingly valuable for this purpose. It creates thin slices through the breast, making it much easier to separate true lesions from layers of normal tissue that just happened to overlap. In a head-to-head comparison, tomosynthesis matched the sensitivity of spot compression views for detecting cancer and achieved higher specificity, meaning it was better at correctly clearing areas that turned out to be normal.¹⁴ Tomosynthesis also helps pin down exactly where in the breast a lesion sits, which matters if a biopsy is eventually needed.²

Ultrasound is the other workhorse tool. It can reveal whether a focal asymmetric density corresponds to a solid mass, a cyst, or nothing more than echogenic (normal-looking) tissue. In one study of 36 women who had a focal asymmetric density and subsequently underwent biopsy, ultrasound found a solid mass in 15 cases, a suspected complicated cyst in two, echogenic tissue in nine, and no focal abnormality at all in ten. Seven of the 36 women (about 19%) turned out to have invasive ductal cancer, and two of those cancer cases had no corresponding abnormality on ultrasound.¹⁵ That last point is worth noting: a clean ultrasound does not completely rule out malignancy when there is a mammographic asymmetry. The negative predictive value of ultrasound in that study was about 89%, meaning roughly one in ten women with a normal ultrasound but a biopsy-worthy asymmetry still had cancer.

Contrast-Enhanced Mammography and Artificial Intelligence

Newer tools are being tested to help resolve ambiguous asymmetries without jumping straight to biopsy. Contrast-enhanced mammography (CEM) involves injecting an iodine-based contrast agent before the mammogram. Because cancers tend to develop new blood vessels (a process called angiogenesis), malignant tissue lights up with the contrast while benign tissue usually does not. In one comparison, CEM outperformed the combination of standard mammography and ultrasound for characterizing breast asymmetries, with higher sensitivity (about 97% versus 86%), higher specificity, and better overall accuracy.¹⁶

Artificial intelligence systems are also being evaluated. In a study comparing AI to contrast-enhanced spectral mammography for assessing various types of breast asymmetries, both approaches reached similar overall accuracy of roughly 73–75%.¹⁷ That is a promising starting point, but it also highlights that neither method is perfect. For now, AI serves more as a second reader alongside the radiologist than as a replacement.

How Hormone Replacement Therapy Can Create New Asymmetries

If you are on or considering hormone replacement therapy (HRT), it is worth knowing that these medications can change what your mammograms look like. Estrogen and progesterone stimulate breast tissue growth, which can create new areas of density or change existing ones. In one longitudinal study, about a quarter of women starting HRT developed increased breast density within a median of 18 months, and several developed new asymmetric densities specifically.¹⁸

The type of HRT matters. Estrogen-only therapy tends to promote cyst and fibroadenoma growth, while combined estrogen-progesterone therapy is more associated with a diffuse increase in breast density.¹⁹ These changes are dynamic and reversible. A large study found that women who started HRT were roughly two and a half times more likely to show increased breast density than non-users, while women who stopped HRT were more likely to show decreasing density.²⁰

This matters for interpreting nodular asymmetries because an HRT-related density change can mimic a suspicious lesion. If you start HRT and your next mammogram shows a new asymmetry, your radiologist will factor in the medication history. In some cases, the clearest test is to repeat imaging a few months after stopping HRT and see if the density resolves. Letting your imaging team know about any hormonal medications, including over-the-counter supplements marketed for menopause, helps avoid unnecessary biopsies.

What Happens If You Need a Biopsy

If additional imaging does not resolve the question, a biopsy is the definitive next step. Most breast biopsies for asymmetric densities are performed with a core needle guided by ultrasound or mammographic stereotactic guidance rather than through surgery. The needle removes small cylinders of tissue that a pathologist examines under a microscope.

For a nodular asymmetry that turns out to be benign, the pathology report might show focal fibrosis, normal fibroglandular tissue, PASH, a radial scar, or some other non-cancerous finding. As discussed earlier, cancer is found in a small minority of asymmetries that go to biopsy. Among the malignancies that do present as asymmetries, the invasive cancers vary in size and pattern, ranging from very small unifocal tumors to cases with multiple foci of invasion.¹⁰

Getting called back for extra imaging after a screening mammogram is stressful. Radiographers in screening programs are aware of this and some clinics have adopted practices like informing first-time screening patients about the possibility of a callback and what it typically means, aiming to reduce anxiety if it does happen.²¹ If you get a callback letter or phone call that mentions an asymmetry, remember that the odds are heavily in your favor. The vast majority of callbacks lead to additional imaging that clears the finding entirely, and even among those that proceed to biopsy, most results are benign.

When a “Stable” Asymmetry Still Deserves Attention

One of the trickier scenarios in breast imaging is the focal asymmetry that has been present on multiple mammograms and appears unchanged. Stability over time is generally reassuring, but it is not an absolute guarantee. Certain slow-growing cancers, particularly invasive lobular carcinoma, can masquerade as a stable asymmetric density for an extended period before revealing their true nature. Research has documented breast carcinomas that manifested as apparently stable focal asymmetries over several screening rounds before eventually being diagnosed.¹³

This does not mean every stable asymmetry needs a biopsy. It means that if you have a longstanding finding your radiologist has been watching, and something about it changes, even subtly, that change should be taken seriously. A slight increase in size, a new area of distortion around the edges, or the development of a palpable lump at the same location all warrant fresh investigation even if the density has been sitting there unremarkably for years. Your comparison mammograms are one of the most powerful tools in this process, which is why imaging centers always ask whether you have prior films from another facility.

Dense Breasts and the Challenge of Finding Asymmetries

Your overall breast density affects how easy or hard it is to detect and evaluate an asymmetry. In breasts that are mostly fatty, a focal area of dense tissue stands out clearly, and additional imaging usually resolves the question quickly. In dense breasts, where fibroglandular tissue makes up a large proportion of the total, small asymmetries can be masked by surrounding tissue or, conversely, normal tissue can create false asymmetries as it overlaps on the mammographic image.

This is one of the areas where tomosynthesis has made the biggest practical difference. By slicing through the breast layer by layer, it separates overlapping tissue and reduces false positives. Contrast-enhanced mammography offers a different advantage: it does not rely on tissue density contrast at all but instead highlights areas of abnormal blood flow, making it useful even in the densest breasts.¹⁶ If you have dense breasts and are told you have a nodular asymmetry, ask your imaging center whether tomosynthesis or contrast-enhanced mammography is available. These tools can often provide a clearer answer and may spare you a biopsy.

1
PubMed. Focal asymmetric densities seen at mammography: US and pathologic correlation
2
PubMed. Developing Asymmetries at Mammography: A Multimodality Approach to Assessment and Management
3
PubMed. Incidence of breast and chest wall asymmetries: 4D photography
4
PubMed Central. New Insights Into Breast and Chest Wall Asymmetry in the Aesthetic Patient
5
PubMed. Focal fibrosis: a common breast lesion diagnosed at imaging-guided core biopsy
6
PubMed. Focal fibrosis of the breast: imaging characteristics and histopathologic correlation
7
PubMed. A case of nodular pseudoangiomatous stromal hyperplasia (PASH)
8
PubMed Central. Multifocal Tumorous Pseudoangiomatous Stromal Hyperplasia Presenting as Asymmetric Bilateral Breast Enlargement
9
PubMed Central. Clinical Images: Radial Scar of the Breast
10
Radiological Society of North America (Radiology). Pathologic Features of Malignancies Presenting as Asymmetry on Mammography
11
PubMed Central. Invasive lobular carcinoma mammographic findings: correlation with age, breast composition, and tumour size
12
PubMed Central. Imaging and pathologic features of non-calcified ductal carcinoma in situ: can sonography predict upgrade?
13
European Society of Radiology. Breast Carcinomas manifesting as stable focal assymetry
14
PubMed. One-to-one comparison between digital spot compression view and digital breast tomosynthesis
15
PubMed. Sonographic evaluation of focal asymmetric density of the breast
16
Egyptian Journal of Radiology and Nuclear Medicine. Diagnostic value of contrast-enhanced mammography in the characterization of breast asymmetry
17
Egyptian Journal of Radiology and Nuclear Medicine. What’s beyond breast asymmetry? Comparative study between artificial intelligence and contrast-enhanced spectral mammography in the assessment of various types of breast asymmetries
18
PubMed. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study
19
PubMed. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy
20
JAMA. Changes in Breast Density Associated With Initiation, Discontinuation, and Continuing Use of Hormone Replacement Therapy
21
PubMed. Communicating the risk of recall in mammography screening – Enskilment in breast radiography